Diuretics and the therapy of hypertension

American Journal of the Medical Sciences

Volumn 319, Issue 1, 2000, Pages 1-9

  Puschett, Jules B ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMILORIDE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUMETANIDE; CALCIUM CHANNEL BLOCKING AGENT; CHLORTALIDONE; CLONIDINE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ETACRYNIC ACID; FUROSEMIDE; HYDROCHLOROTHIAZIDE; LISINOPRIL; LOOP DIURETIC AGENT; METOLAZONE; NIFEDIPINE; POTASSIUM SPARING DIURETIC AGENT; PRAZOSIN; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; TORASEMIDE; TRIAMTERENE;

ANTIHYPERTENSIVE THERAPY; ARTICLE; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG SAFETY; HUMAN; HYPERTENSION; RISK BENEFIT ANALYSIS;

EID: 0034130055     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9629(15)40675-5     Document Type: Article

References (60)

1. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1993;153:154-83.
2. Kaplan NM. Clinical hypertension. 7th ed. Baltimore: Williams & Wilkins; 1998. p. 13.
3. Laragh JH. Vasoconstriction-Volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles. Am J Med 1973;55:261-74.
4. Laragh JH. Renin profiling for diagnosis, risk assessment, and treatment of hypertension. Kidney Int 1993;44:1163-75.
5. Gifford RW, Mattox VR, Orvis AL, et al. Effect of thiazide diuretics on plasma volume, body electrolytes, and excretion of aldosterone in hypertension. Circulation 1961;24:1197-205.
6. Wilson IM, Freis ED. Relationship between plasma and extracellular fluid volume depletion and the antihypertensive effect of chlorothiazide. Circulation 1959;20:1028-36.
7. Villarreal H, Exaire JE, Revollo A, et al. Effects of chlorothiazide on systemic hemodynamics in essential hypertension. Circulation 1962;26:405-8.
8. Moser M. Diuretics in the management of hypertension. Med Clin North Am 1987;71:5:935-46.
9. Puschett JB, O'Donovan R. Diuretic use in edematous and nonedematous conditions: current therapy. In: Glassock RG, editor. Nephrology and hypertension. 4th ed. Philadelphia: Mosby; 1998. p. 386-99.
10. Loon NR, Wilcox CS, Unwin RJ. Mechanism of impaired natriuretic response to furosemide during prolonged therapy. Kidney Int 1989;36:682-9.
11. Achhammer I, Eberhard R. Comparison of serum potassium levels during long-term treatment of hypertensive patients with 2.5 mg torasemide/day or 50 mg triamterene/25 mg hydrochlorothiazide/day. In: Kruck F, Mutschier E, Knauf H, editors. Progress in pharmacology and clinical pharmacology. Vol. 8. New York: Gustav Fischer Verlag; 1990. p. 211-20.
12. McMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease. Part I. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilutional bias. Lancet 1990;335: 765-74.
13. Multiple Risk Factor Intervention Trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group. JAMA 1982;248:1465-77.
14. Houston MC. New insights and new approaches for the treatment of essential hypertension: selection of therapy based on coronary heart disease risk factor analysis, hemodynamic profiles, quality of life, and subsets of hypertension. Am Heart J 1989;117:911-51.
15. Zusman RM. Alternatives to traditional antihypertensive therapy. Hypertension 1986;8:837-42.
16. O'Donovan R, Muhammedi M, Puschett, JB. Diuretics in the therapy of hypertension: current status. Am J Med Sci 1992;304:312-8.
17. Kaplan NM. Diuretics: cornerstone of antihypertensive therapy. Am J Cardiol 1996;77:3B-5B.
18. Freis ED. The efficacy and safety of diuretics in treating hypertension. Ann Intern Med 1995;122:223-6.
19. Weir MR, Flack JM, Applegate WB. Tolerability, safety, and quality of life and hypertensive therapy: The case for low-dose diuretics. Am J Med 1996;101(Suppl. 3A):83S-92S.
20. Flack JM. Evidence for the efficacy of low-dose diuretic monotherapy. Am J Med 1996;101(Suppl. 3A):53S-60S.
21. McVeigh G, Galloway D, Johnston D. The case for low dose diuretics in hypertension: comparison of low and conventional doses of cyclopenthiazide. BMJ 1988;297:95-8.
22. Holland OB, Nixon JV, Kuhnert I. Diuretic-induced ventricular ectopic activity. Am J Med 1981;770:762-8.
23. Hollifield JW, Slaton PE. Thiazide diuretics, hypokalemia and cardiac arrhythmias. Acta Med Scand 1981;647(suppl): 67-73.
24. Hoes AW, Grobbee DE, Lubsen J, et al. Diuretics, β-blockers, and the risk for sudden cardiac death in hypertensive patients. Ann Intern Med 1995;123:481-7.
25. Duke M. Thiazide-induced hypokalemia. Association with acute myocardial infarction and ventricular fibrillation. JAMA 1978;239:43-5.
26. Ventricular extrasystoles during thiazide treatment: substudy of MRC mild hypertension trial. Br Med J (Clin Res Ed) 1983;287:1249-53.
27. Stewart DE, Ikram H, Espiner EA, et al. Arrhythmogenic potential of diuretic induced hypokalemia in patients with mild hypertension and ischaemic heart disease. Br Heart J 1985;54:290-7.
28. Papademetriou V, Burris JF, Notargiacomo A, et al. Thiazide therapy is not a cause of arrhythmia in patients with systemic hypertension. Arch Intern Med 1988;1272-6.
29. Savage PJ, Pressel SL, Curb JD, et al. Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: the Systolic Hypertension in the Elderly Program. Arch Intern Med 1998; 158:741-51.
30. Neutel JM. Metabolic manifestations of low-dose diuretics. Am J Med 1996;101(Suppl. 3A):71S-82S.
31. Siscovick DS, Raghunathan TE, Psaty BM, et al. Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med 1994;330:1852-7.
32. Siegel D, Hulley SB, Black DM, et al. Diuretics, serum and intracellular electrolyte levels, and ventricular arrhythmias in hypertensive men. JAMA 1992;267:1083-9.
33. Haalboom JRE, Bouter H, Kuyer PPJ, et al. Hypokalemia in hypertensive patients treated with diuretics: No increase in cardiac arrhythmias. Neth J Med 1989;34:81-7.
34. Madias JE, Madias NE, Gavras HP. Nonarrhythmogenicity of diuretic-induced hypokalemia. Arch Intern Med 1984; 144:2171-6.
35. Peters RW, Hamilton J, Hamilton BP. Incidence of cardiac arrhythmias associated with mild hypokalemia induced by low-dose diuretic therapy for hypertension. South Med J 1989;82:966-9.
36. Ames RP. The effects of antihypertensive drugs on serum lipids and lipoproteins, I. Diuretics. Drugs 1986;32:260-78.
37. Goldman AI, Steele BW, Schnaper HW, et al. Serum lipoprotein levels during chlorthalidone therapy. JAMA 1980; 244:1691-5.
38. Grimm RH, Leon AS, Hunninghake DB, et al. Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients. Ann Intern Med 1981;94:7-11.
39. Lasser NL, Grandits G, Caggiula AW, et al. Effects of antihypertensive therapy on plasma lipids and lipoproteins in the multiple risk factor intervention trial. Am J Med 1984;76:52-66.
40. Weidmann P, Gerber A. Effects of treatment with diuretics on serum lipoproteins. J Cardiovasc Pharmacol 1984;6: S260-8.
41. Weinberger MH. Treatment of hypertension in the 1990s. Am J Med 1987;82:44-9.
42. Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressures averaging 90 through 114 mm Hg. JAMA 1970;213:1143-52.
43. Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Hypertension Detection and Follow-up Program Cooperative Group. JAMA 1979;242:2562-71.
44. Amery A, Birkenhager W, Brixko P, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet 1985;1(8442): 1349-54.
45. MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party. Br Med J (Clin Res Ed) 1985;291:97-104.
46. Oslo Study. Treatment of mild hypertension. A five-year controlled drug trial. Am J Med 1980;69:725-32.
47. Systolic Hypertension in the Elderly Program. Antihypertensive efficacy of chlorthalidone. Am J Cardiol 1985;56:913-20.
48. Greenberg G, Brennan PJ, Miall WE. Effects of diuretic and beta-blocker therapy in the medical research council trial. Am J Med 1984;45-51.
49. Neaton JD, Grimm RH, Prineas RJ, et al. Treatment of mild hypertension study. JAMA 1993;270:713-24.
50. Warram JH, Laffel LMB, Valsania P, et al. Excess mortality associated with diuretic therapy in diabetes mellitus. Arch Intern Med 1991;151:1350-6.
51. Curb JD, Pressel SL, Cutler JA, et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. JAMA 1996;276:1886-92.
52. Kostis JB, Davis BR, Cutler J, et al. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1997;278:212-6.
53. Moser M, Hebert PR. Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials. J Am Coll Cardiol 1996;27:1214-8.
54. Moser M. Diuretics in the prevention and treatment of congestive heart failure. Cardiovasc Drugs Ther 1997;11: 273-7.
55. Gottdiener JS, Reda DJ, Massie BM, et al. Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Circulation 1997;95:2007-14.
56. Curry CL, Robinson H, Brown R, et al. Regression of left ventricular hypertrophy in patients with essential hypertension. Am J Hypertens 1996;828-32.
57. Ofili EO, Cohen JD, St. Vrain JA, et al. Effect of treatment of isolated systolic hypertension on left ventricular mass. JAMA 1998;279:778-80.
58. Schlaich MP, Schmieder RE. Left ventricular hypertrophy and its regression: pathophysiology and therapeutic approach. Am J Hypertens 1998;11:1394-404.
59. Siegel D, Lopez J. Trends in antihypertensive drug use in the United States. JAMA 1997;1745-8.
60. Valvo E, D'Angelo A, Maschio G. Diuretics in hypertension. Kidney Int Suppl 1997;59:S36-8.